Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Recent & Breaking News (TSXV:TLT)

Microcap Report: Theralase Tech. (V.TLT), Enablence Tech. (V.ENA) active

Stockhouse Editorial June 18, 2014

Theralase Technologies (V.TLT) teams with University of Toledo in cancer study

Stockhouse Editorial June 18, 2014

Theralase Partners with University of Toledo in Cancer Research

TheNewsWire June 18, 2014

Theralase's Cancer Technology Demonstrates Vaccine-Like Properties

Accesswire June 16, 2014

14 stocks Stockhouse staffers think will have a big June

Stockhouse Editorial June 15, 2014

Microcap Report: PanTerra (V.PRC), Theralase Tech. (V.TLT) active

Stockhouse Editorial June 12, 2014

Theralase Technologies (V.TLT) bumps 6% on OTC market upgrade

Gaalen Engen June 12, 2014

Theralase Stock Upgraded on US OTC Market

TheNewsWire June 12, 2014

CBC TV interviews Theralase (V.TLT) CEO on corporate strategy and shares pop 7%

Stockhouse Editorial June 5, 2014

Theralase CEO Interviewed by CBC TV about Progress in Anti-Cancer and Pain Research

TheNewsWire June 5, 2014

Microcap Report: Papuan Precious Metals (V.PAU) Theralase Tech (V.TLT) active

Stockhouse Editorial June 2, 2014

Theralase Laser Technology Used By Star Athletes for Pain Management

Accesswire June 2, 2014

Theralase Releases 1Q2014 Financial Results

TheNewsWire May 30, 2014

Bob Moriarty told readers to “shut up and buy Theralase” (V.TLT)

Stockhouse Editorial May 30, 2014

Limitless Venture Group To Hold Public Q&A

Accesswire May 30, 2014

Microcap Report: Theralase Tech. (V.TLT), Sirona Biochem (V.SBM), Xmet (V.XME) active

Stockhouse Editorial May 29, 2014

Theralase Technologies (V.TLT) discovers cancer immunity response and shares climb 64%

Gaalen Engen May 29, 2014

Theralase Discovers Anti-Cancer Memory Response

TheNewsWire May 29, 2014

Theralase Anti-Cancer Technology Validated in Prestigious US Chemistry Publication

TheNewsWire May 27, 2014

Zack's Research Initiates Coverage on Theralase With a Price Target of $1.00

Accesswire May 20, 2014